Sort
40,608 grants matching “prostate cancer”
Ovcoming PARP Inhibitor Resistance
$633,705Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2025 · CA
Multi-cohort validation of machine learning radiogenomic models (ML-RGx) to predict late toxicity in prostate cancer
$633,691Sarah L. Kerns · Medical College Of Wisconsin · R01 · FY2025 · CA
Defining the epigenetic landscape in human prostate cancer
$633,613Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression
$633,508Edward Giovannucci · Harvard School Of Public Health · R01 · FY2011 · CA
Biomarker Approaches to Individualizing Systemic Therapy for High Risk Prostate Cancer
$633,505Felix Yi-Chung Feng · University Of California, San Francisco · R01 · FY2021 · CA
Advanced diffusion MRI for evaluating early response to radiation treatment in cervical cancer
$633,459Rebecca Ann Rakow-Penner · University Of California, San Diego · R37 · FY2023 · CA
Population Modeling of Bladder Cancer Detection and Control
$633,411Thomas Trikalinos · Brown University · U01 · FY2024 · CA
Hormones and Cytokines in CaP risk and recurrence
$633,395Brigham And Women'S Hospital · R01 · FY2003 · CA
Improving Urinary Continence and Quality of Life in Prostate Cancer Patients
$633,291Amy Y Zhang · Case Western Reserve University · R01 · FY2010 · CA
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer
$633,229Esther H Chang · Georgetown University · R01 · FY2009 · CA
Personal Patient Profile-Prostate: Testing and Implementation in Health Networks
$633,220Donna L. Berry · Dana-Farber Cancer Inst · R01 · FY2013 · NR
Clinical trials employing cancer vaccine combination therapies
$633,201James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$633,201James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer
$633,122Christopher A Maher · Washington University · R01 · FY2025 · CA
Interference with Androgen Receptor and Its Ligands
$633,005James L Mohler · Univ Of North Carolina Chapel Hill · P01 · FY2010 · CA
3D High Resolution Magnetic Resonance Fingerprinting for Prostate Cancer
$632,972Yun Jiang · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT Prostate
$632,943Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2022 · CA
RNA-binding as a new paradigm for androgen receptor-mediated prostate cancer therapeutic resistance
$632,906Yan Dong · Tulane University Of Louisiana · R01 · FY2025 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$632,887Joel L Weissfeld · · N01 · FY2009 · CA
Multichannel Fluorescence Guided Surgery Tools Enabling Simultaneous Cancer Margin and Nerve Visualization in Prostatectomy
$632,874Summer Lynne Gibbs · Oregon Health & Science University · R01 · FY2022 · CA
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients
$632,659Daniel B Vigneron · University Of California, San Francisco · R01 · FY2024 · CA
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$632,597Kathleen Siebenlist · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$632,596Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2015 · CA
Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC
$632,590Susan Halabi · Duke University · R01 · FY2022 · CA
A SHARED TISSUE RESOURCE FOR THE MOLECULAR CLASSIFACTION
$632,572University Of Pittsburgh At Pittsburgh · U01 · FY2003 · CA